COMPOSITIONS AND METHODS FOR THE TREATMENT OF LEUKODYSTROPHY AND WHOLE ANIMAL AND CELLULAR MODELS FOR IDENTIFYING EFFICACIOUS AGENTS FOR TREATMENT OF THE SAME

ALTERING INFLAMMATORY STATES OF IMMUNE CELLS IN VIVO BY MODULATING CELLULAR ACTIVATION STATES

ISCHEMIA/REPERFUSION INJURY

COMBINATION THERAPY FOR THE TREATMENT OF CANCER

Nutritional composition, a preparation method therefor, and uses thereof

TREATMENT FOR GINGIVITIS

REELIN COMPOSITIONS FOR TREATMENT OF NEUROLOGICAL DISORDERS

Composition and Use Method Therefor

PHARMACEUTICAL COMPOSITION COMPRISING RUNX3 GENE OR PROTEIN AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF K-RAS MUTANT LUNG CANCER

FINE-TUNING INFLAMMATION BY ALTERING 3'UTR LENGTH

METHODS OF INCREASING READTHROUGH OF A PREMATURE TERMINATION CODON

Composition, Method, And Use of Netrin-1 In Preserving the Bone Marrow Niche to Promote Stem Cell Health

METHODS FOR INCREASING TYPE I, III, AND V COLLAGEN IN AN ANIMAL

METHOD FOR ENHANCING TRANSFERRIN RECEPTOR-BASED TRANSCYTOSIS ACROSS THE BLOOD BRAIN BARRIER

Compositions and Methods for Delivering CFTR Polypeptides

HTT REPRESSORS AND USES THEREOF

GLYCOTARGETING THERAPEUTICS

COMPOSITIONS COMPRISING PROTEIN DISULFIDE ISOMERASE AND METHODS OF PRODUCTION AND USE THEREOF

Secretoglobins for Suppression of Antibody Responses

PARTIAL EPIGENETIC REPROGRAMMING FOR LIVER DISEASE TREATMENT

REJUVENATING THE AGED SKELETAL MICROENVIRONMENT TO REVERSE AGE-RELATED BONE LOSS

GENE THERAPY TREATMENT

COMPOSITIONS AND METHODS UTILIZING A NOVEL HUMAN FOXO3 ISOFORM

METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING ATHEROSCLEROSIS AND RELATED DISEASES

ENGINEERING NON-CYTOTOXIC DELIVERY OF PROTEINS BY T CELLS VIA FUSION TO NPC2

METHOD OF PREVENTING AND/OR TREATING CANCER BY SMALL- MOLECULE PROTEIN

PRODUCTION OF RECOMBINANT LUBRICIN

USE OF A SMALL NATIVE PEPTIDE ACTIVATOR OF SERCA PUMP FOR TREATMENT OF HEART FAILURE AND OTHER DISORDERS CHARACTERIZED BY CYTOSOLIC CALCIUM OVERLOAD

PHARMACEUTICAL COMPOSITION CONTAINING CBFbeta-EXPRESSING VASCULAR SMOOTH MUSCLE CELLS OR CULTURE FLUID THEREOF AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF AGE-RELATED DISEASES

GENE THERAPY FOR FOXG1 SYNDROME

COMPOSITIONS AND METHODS FOR ENHANCING WNT SIGNALING FOR TREATING CANCER

COMPOSITIONS AND METHODS FOR TREATING CANCER

System and Method for the Production, Formulation and Use of Conditioned Media, Cultured Cells and the Factors Included Therein

Method of Inhibiting Durotaxis and/or Treating Fibrosis

TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS

METHOD FOR ROBOTIC ASSISTED HEART TRANSPLANT

CD40L-SPECIFIC TN3-DERIVED SCAFFOLDS FOR THE TREATMENT AND PREVENTION OF SJÖGREN'S SYNDROME

LOCO-REGIONAL PERFUSION OF A KIDNEY

RETROGRADE CORONARY VENOUS OR SINUS ADMINISTRATION OF THERAPEUTICS

Nutritive Polypeptides and Formulations Thereof, and Methods of Production and Use Thereof

METHODS OF ALTERING BONE GROWTH BY ADMINISTRATION OF SOST OR WISE ANTAGONIST OR AGONIST

METHODS AND COMPOSITIONS OF TREATING RETINAL DEGENERATIVE DISEASES

COMPOSITIONS AND SYNERGISTIC METHODS FOR TREATING INFECTIONS

P21 Expressing Monocytes for Cancer Cell Therapy

CELLULAR REPROGRAMMING TO REVERSE AGING AND PROMOTE ORGAN AND TISSUE REGENERATION

METHOD FOR PRODUCING NONHUMAN PRIMATE ANIMAL MODEL OF CEREBRAL INFARCTION AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF CEREBRAL INFARCTION

MATERIALS AND METHODS FOR TREATING FRIEDREICH'S ATAXIA

EPIGENETIC MODULATION OF GENOMIC TARGETS TO CONTROL EXPRESSION OF PWS-ASSOCIATED GENES

COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES, DISORDERS, AND CONDITIONS

HEMOPEXIN FORMULATIONS

ENHANCEMENT OF PHAGOCYTOSIS

NOVEL AAV3B CAPSID VARIANTS WITH ENHANCED HEPATOCYTE TROPISM

COMPOSITIONS FOR DRINKING WATER

IL-2 SUPERAGONISTS IN COMBINATION WITH ANTI-PD-1 ANTIBODIES

SLC26A4 REGULATORY ELEMENTS AND USES THEREOF

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY

EPICARDIAL-DERIVED PARACRINE FACTORS FOR REPAIRING CARDIAC TISSUE

METHODS AND DEVICES FOR PROMOTING NERVE GROWTH AND REGENERATION

METHODS AND COMPOSITIONS FOR TUSC2 IMMUNOTHERAPY

ANTI-SYNUCLEINOPATHY PEPTIDE AND METHODS TO TREAT NEURODEGENERATIVE DISEASES

Compositions and Methods for Inhibiting T Cell Exhaustion

COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT

DAIRY PRODUCT AND PROCESS

Adeno-Associated Virus Variant Capsids with Improved Lung Tropism and Uses Thereof

CELLULAR REPROGRAMMING TO REVERSE AGING AND PROMOTE ORGAN AND TISSUE REGENERATION

BAG3 METHODS AND USES FOR TREATMENT OF INFLAMMATION

A BIOENGINEERED AAV9 VECTOR CARRYING OPTIMIZED TRANSGENE FOR DUCHENNE MUSCULAR DYSTROPHY GENE THERAPY AND METHOD THEREOF

GENE THERAPY FOR FAM161A-ASSOCIATED RETINOPATHIES AND OTHER CILIOPATHIES

SMALL ACTIVATING RNA (saRNA) CAPABLE OF ACTIVATING CCAAT ENHANCER BINDING PROTEIN ALPHA (CEBPA) GENE, AND DELIVERY SYSTEM AND USE THEREOF

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND AUTOIMMUNE CONDITIONS WITH ECM-AFFINITY PEPTIDES LINKED TO ANTI-INFLAMMATORY AGENTS

COMPOSITIONS AND METHODS FOR ANTIGEN-SPECIFIC TOLERANCE

USE OF CELL MEMBRANE-BOUND SIGNALING FACTORS

METHODS AND COMPOSITIONS FOR IMMUNOMODULATION

HETEROCYCLES AND USES THEREOF

COMPOSITIONS AND METHODS OF USE FOR THE TREATMENT OF DIABETES

METHODS FOR AFFECTING TISSUE-RESIDENT T CELLS

mRNA LIPID NANOPARTICLES FOR THE TREATMENT OF NIEMANN-PICK TYPE C DISEASE

COMPOSITIONS AND METHODS FOR EXPRESSING OTOFERLIN

VECTOR-BASED GENE THERAPY FOR ELONGATOR ACETYLTRANSFERASE COMPLEX SUBUNIT 1 (ELP1)

COMPOSITIONS COMPRISING PEDF-DERIVED SHORT PEPTIDES FOR THE TREATMENT OF DRY EYE DISEASES

METHODS FOR TREATING ACUTE CONDITIONS USING LIPID BINDING PROTEIN-BASED COMPLEXES

Modification and Compositions of Human Secretoglobin Proteins

METHOD FOR TREATMENT OF MYOTONIC DYSTROPHY COMBINING PROTEIN EXPRESSION AND RNA INTERFERENCE VECTOR DELIVERY WITH TISSUE DETARGETING

TRANSDERMAL DELIVERY DEVICE FOR PEPTIDE DELIVERY AND METHODS OF USE

NANOLIPOSOME COMPOSITIONS AND METHODS OF USING THE SAME

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING FOXM1 MUTANT OR FOXM1 SHRNA

TREATMENT OF INFLAMMATORY CONDITIONS BY DELIVERY OF INTERLEUKIN-1 RECEPTOR ANTAGONIST FUSION PROTEIN

ISOFORM NELL-1 PEPTIDE

ANNEXIN A1 LIQUID PHARMACEUTICAL COMPOSITION

COMPOSITIONS AND METHODS FOR THE TREATMENT OF SEPSIS

Dry Powder Formulations for Messenger RNA

PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING FOXM1 MUTANT OR FOXM1 SHRNA

COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER

GENE THERAPY DELIVERY COMPOSITIONS AND METHODS FOR TREATING HEARING LOSS

COMPOSITIONS AND METHODS FOR TREATING CANCER BY INCREASING EXPRESSION OF OBSCN-AS1 LONG-NONCODING RNA

MONOMERIC ANNEXIN A5 FOR USE IN THE TREATMENT OF MACULAR OEDEMA OR RETINAL VEIN OCCLUSION

FUNCTIONAL POROSOME MANIPULATION

CELL CONVERSION

COMBINATION THERAPY FOR CLASSIC HODKIN'S LYMPHOMA

CONTROLLED EXPRESSION OF THERAPEUTICALLY RELEVANT BIOMOLECULES FOR LUMEN-LOCALIZED PAYLOADS IN BIOMIMETIC NANOVESICLES AND EXOSOMES

MATERIALS AND METHODS FOR TARGETING REGULATORY T CELLS FOR ENHANCING IMMUNE SURVEILLANCE

TREATMENT OF DISEASES RELATED TO COLONY-STIMULATING FACTOR 1 RECEPTOR DYSFUNCTION USING TREM2 AGONISTS

Compositions of Phosphorylated Tau Peptides and Uses Thereof

REVERSING AGING OF THE CENTRAL NERVOUS SYSTEM

TREATMENT OF NOCICEPTIVE PAIN

POWDERS CONTAINING A BUFFER SALT AND AN AMINO ACID, RECONSTITUTION OF SUCH A POWDER INTO A NUTRITIONAL PRODUCT, AND METHODS OF USING SUCH A NUTRITIONAL PRODUCT

RAAV VECTOR FOR THE TREATMENT OF COX20 DEFICIENCY

TREATMENTS FOR AGE-RELATED CELLULAR DYSFUNCTION

NOVEL METHODS AND COMPOSITION OF AAV VECTORS FOR THE TREATMENT OF FRIEDREICH'S ATAXIA

COMPOSITIONS FOR RESTORING MECP2 GENE FUNCTION AND METHODS OF USE THEREOF

RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR FOR TREATMENT OF IRON-ACCUMULATING NEURODEGENERATIVE DISEASES

DAP12 CONSTRUCTS AND THEIR USE TO ENHANCE DC VACCINES AND IMMUNOTHERAPIES

METHOD

LIPOPROTEIN COMPLEXES AND MANUFACTURING AND USES THEREOF

COMPOSITIONS AND METHODS FOR TREATING NON-AGE-ASSOCIATED HEARING IMPAIRMENT IN A HUMAN SUBJECT

METHOD FOR CONSTRUCTING HOTSPOT-DERIVED PEPTIDE-NUCLEIC ACID HYBRID MOLECULES ON BASIS OF IN VITRO SELECTION

REPROGRAMMED FUNCTIONAL FRAGMENT OF RECOMBINANT ONCOLYTIC VIRUS, COMBINATION, AND APPLICATION THEREOF

DEFORMABLE NANO-SCALE VEHICLES (DNVS) FOR TRANS-BLOOD BRAIN BARRIER, TRANS-MUCOSAL, AND TRANSDERMAL DRUG DELIVERY

LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF

Gene Therapy For Neurodegenerative Disorders

ENGINEERED SIRPá VARIANTS AND METHODS OF USE THEREOF

COMPOSITION FOR INDUCING REVERSE-AGING CONTAINING SLIT2 AND METHOD FOR INDUCING REVERSE-AGING

MICRO-DYSTROPHIN FOR HEART PROTECTION

PEG LIPIDOID COMPOUNDS

TREATMENT OF DISEASES RELATED TO ATP-BINDING CASSETTE TRANSPORTER 1 DYSFUNCTION USING TREM2 AGONISTS

METHOD AND COMPOSITIONS FOR NEURONAL REPROGRAMMING

Methods of Treating Retinal Degenerative Diseases Using AIMP2-DX2 and Optionally a Target Sequence for miR-142 and Compositions Thereof

METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS

SQSTM1 AND ITS USE IN CANCER THERAPY

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY CONDITIONS ASSOCIATED WITH INFECTIOUS DISEASE

POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF

SYNERGISTIC COMBINATION OF RDCFV2 AND RDCVF2L FOR THE TREATMENT OF TAUOPATHIES

HISTATIN COMBINATIONS AND METHODS FOR TREATING OR INHIBITING CELL LOSS

METHODS OF TREATING FRIEDREICH'S ATAXIA

COMPOSITION FOR THE INHIBITION OF NRF2 AND USES THEREOF IN CANCER THERAPY

PTEROSTILBENE AND SILIBININ FOR PREVENTING, AMELIORATING OR REDUCING RADIATION-INDUCED DISEASES

B-CELL LYMPHOMA 2-ASSOCIATED ANTHANOGENE 3 (BAG3) GENE THERAPY USING AAV VECTOR

HUMAN EPENDYMA-SPECIFIC PROMOTER AND USES THEREOF

THERAPEUTIC LAMA2 PAYLOAD FOR TREATMENT OF CONGENITAL MUSCULAR DYSTROPHY

METHODS AND COMPOSITIONS FOR MODULATION OF TAU PROTEINS

METHOD OF TREATING, AMELIORATING AND/OR PREVENTING POLYCYSTIC KIDNEY DISEASE

PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS

METHOD FOR PREVENTING OR TREATING CANCER BY BLOCKING EXCESSIVE PRODUCTION OF PHOSPHORYLATED VIMENTIN

ICE-BASED LIPID NANOPARTICLE FORMULATIONS FOR DELIVERY OF MRNA

METHODS FOR TREATING LEUKOCYTOSIS, ENDOTHELIAL DYSFUNCTION AND CARDITIS USING LIPID BINDING PROTEIN-BASED COMPLEXES

LYOPHILIZED LIPID NANOPARTICLES AND METHODS OF THEIR USE

CAPSIDS FOR PLAKOPHILLIN-2 GENE THERAPY

TRANSLATION ENHANCING NUCLEIC ACID COMPOUNDS: ASO COUPLED TRANSLATION – UPREGULATION 1 (ACT-UP1) AND USES THEREOF

PLAKOPHILLIN-2 GENE THERAPY TREATMENT METHODS

ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)

ENGRAFTMENT OF STEM CELLS WITH A COMBINATION OF AN AGENT THAT TARGETS STEM CELLS AND MODULATION OF IMMUNOREGULATORY SIGNALING

METHODS OF MODULATING PROGRANULIN EXPRESSION USING ANTISENSE OLIGONUCLEOTIDES TARGETING REGULATORY RNAS

COMPOSITIONS AND METHODS FOR TREATING SENSORINEURAL HEARING LOSS, VESTIBULAR DYSFUNCTION AND VISION LOSS USING PROTOCADHERIN 15 DUAL VECTOR SYSTEMS

RECOMBINANT THERAPEUTIC FMR1 CONSTRUCTS AND METHODS OF TREATING FRAGILE X SYNDROME AND RELATED DISORDERS

HEPARIN-ASSOCIATED POLYPEPTIDES AND USES THEREOF

NANOLIPOSOME COMPOSITIONS AND METHODS OF TREATING STROKE

TARGETTING ACTIVITY OF THE MITF FAMILY AS A THERAPEUTIC FOR REGULATING GENE EXPRESSION NETWORKS IMPLICATED IN B CELL HOMEOSTASIS, GERMINAL CENTER RESPONSES, AND TOLERANCE

NON-OPIOID METHODS FOR TREATING PAIN

THERAPEUTIC AND DIAGNOSTIC METHODS AND COMPOSITIONS FOR NEURODEGENERATIVE DISEASES

PERMANENT EPIGENETIC GENE SILENCING

METHODS FOR IMPROVING ADENO-ASSOCIATED VIRUS (AAV) DELIVERY

CARDIO-PROTECTIVE EFFECT OF VASOCONSTRICTION-INHIBITING FACTOR (VIF)

Compositions and Methods for Treating Striatonigral Degeneration

DAIRY PRODUCT AND PROCESS

GENE THERAPY DELIVERY COMPOSITIONS AND METHODS FOR TREATING HEARING LOSS

ADENO-ASSOCIATED VIRUS VECTORS FOR NUCLEIC ACID DELIVERY ACROSS RETINAL REGIONS

Treatment for Ocular Fibrosis

PROCESSES FOR MAKING AND USING A MESENCHYME STEM CELL SECRETOME FOR LIMBAL STEM CELL DEFICIENCY (LSCD) TREATMENT

POLYNUCLEOTIDES ENCODING FANCONI ANEMIA, COMPLEMENTATION GROUP PROTEINS FOR THE TREATMENT OF FANCONI ANEMIA

Cochlear and/or vestibular cell specific promoter and use thereof

ADENO-ASSOCIATED VIRUS VECTORS FOR NUCLEIC ACID DELIVERY TO RETINAL GANGLION CELLS AND/OR RETINAL PIGMENT EPITHELIUM CELLS

USE OF BOVINE SPLEEN PEPTIDE POWDER IN IMPROVING SLEEP, PREVENTING OR TREATING DEPRESSION, OR IMPROVING INTESTINAL FUNCTION

COMPOSITIONS AND METHODS

Method of Treating Osteoarthritis

CONSTRUCTS, VIRAL VECTORS AND PHARMACEUTICAL COMPOSITIONS COMPRISING LONG NONCODING RNA ANRIL FOR TREATMENT OF DISEASE

PHYTOECDYSONES AND/OR 20-HYDROXYECDYSONE DERIVATIVES IN COMBINATION WITH AN ACTIVE INGREDIENT FOR RESTORING SMN EXPRESSION, FOR USE IN THE TREATMENT OF SPINAL MUSCULAR ATROPHY

ACTIVIN RECEPTOR TYPE IIB VARIANTS AND METHODS OF USE THEREOF

Intrathecal Delivery of Recombinant Adeno-Associated Virus 9

METHODS AND COMPOSITIONS FOR TREATING RBM20 RELATED CARDIOMYOPATHY WITH A VIRAL VECTOR

DRUG AND METHOD FOR FORMING GABAERGIC NEURONS

Unknown

USE OF FOLLISTATIN-LIKE 1 (FSTL1) IN CARDIOMETABOLIC HEART FAILURE

SYSTEMS, METHODS, AND COMPOSITIONS FOR RESCUING PROTEIN MISFOLDING

CD300LD INHIBITOR AND USE THEREOF IN THE PREPARATION OF TUMOR IMMUNOTHERAPY PRODUCTS

NUTRITIONAL COMPOSITION

PROCESSES FOR MAKING AND USING A CELLULAR FIBRONECTIN COMPOSITION

NATURAL TISSUE SCAFFOLDS AS TISSUE FILLERS

METHODS FOR REGULATING FREE FATTY ACID FLUX USING FAT SPECIFIC PROTEIN 27 (FSP27) COMPOSITIONS

USE OF ANNEXINS IN PREVENTING AND TREATING CARDIAC NEURONAL CELL MEMBRANE INJURY AND DISEASE

PHOSPHORYLATION OF P53 AS A PROGNOSTIC OR DIAGNOSTIC MARKER FOR THE TREATMENT OF SENESCENT CELLS IN A MAMMAL

METHODS FOR NEURAL REGENERATION IN VIVO AND USES THEREOF

Compositions and Methods for Diagnosing and Treating Intellectual Disabilities

Compositions and Methods to Prevent, Inhibit or Treat Autoimmune and Vascular Disease

RECOMBINANT PROTEIN FOR ULCERATIVE COLITIS TREATMENT OR PREVENTION AND COMPOSITION FOR ULCERATIVE COLITIS TREATMENT OR PREVENTION CONTAINING THE SAME

HUMAN UMBILICAL CORD COMPOSITION FOR TREATMENT OF PEYRONIE'S DISEASE

Materials & Methods for Treatment of Macular Degeneration

LIPID NANOPARTICLE COMPOSITIONS AND USES THEREOF

SCO-spondin-derived polypeptides for enhancing synaptic transmission

Antisecretory Factor for Use in Treatment and/or Prevention of Acute Respiratory Failure

HIF-1 ACTIVATORS AND USES THEREOF

PERITONEAL DIALYSIS FLUID COMPOSITION COMPRISING A COMPLEMENT INHIBITOR

THERAPEUTIC FACTORS FOR THE TREATMENT OF POLYQ DISEASES

C-TYPE NATRIURETIC PEPTIDE VARIANTS TO TREAT SKELETAL DYSPLASIA IN CHILDREN

COMPOSITIONS AND METHODS OF TREATING AMYOTROPHIC LATERAL SCLEROSIS (ALS) AND RELATED DISORDERS

SYNERGISTIC COMPOSITIONS FOR IMPROVING MINERAL BIOACCESSIBILITY

TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS

DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY

METHODS OF GENERATING A POPULATION OF NEURONS FROM HUMAN GLIAL PROGENITOR CELLS AND GENETIC CONSTRUCTS FOR CARRYING OUT SUCH METHODS

ADENO-ASSOCIATED VIRUS VECTOR DELIVERY OF MICRO-DYSTROPHIN TO TREAT MUSCULAR DYSTROPHY

COMPOSITIONS AND METHODS FOR TREATING DISEASE

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY ASSOCIATED WITH FRIEDREICH ATAXIA

PEPTIDIC INHIBITORS OF AMYLOID SELF- AND CROSS-ASSEMBLY

Medical application and pharmaceutical composition of UbV.E4B protein

PREVENTING ALU SINES-MEDIATED PATHOLOGIES

LUTEIN FOR USE IN INHIBITING MAST CELL DEGRANULATION

DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY

DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY

HYDRODYNAMIC GENE DELIVERY

COMPLEXES FOR TREATING SENSITIVITY

Mutant Peptides And Methods Of Treating Subjects Using The Same

COMPOSITIONS AND METHODS FOR TREATING METABOLIC DISORDERS

COMPOSITION FOR PREVENTION OR TREATMENT OF DRY EYE DISEASE COMPRISING HAPLN1

UTERINE CANCER TREATMENTS

METHODS USING SURFACE-EXPRESSIBLE ACTIVATABLE EPITOPES TO LOCALIZE AND/OR TREAT DISEASED CELLS

TREATMENT OF ACQUIRED FOCAL EPILEPSY

DISRUPTION OF THE SECRETION OF INSULIN-LIKE GROWTH FACTOR 2 FOR CANCER TREATMENT

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS

COMPOSITIONS AND METHODS FOR TREATING CENTRAL NERVOUS SYSTEM INJURY

METHODS AND COMPOSITIONS FOR TREATING DRY EYE, TEAR HYPEROSMOLARITY-INDUCED PATHOLOGICAL CHANGES, AND OTHER OCULAR CONDITIONS

MODIFIED EXTRACELLULAR VESICLES THAT SPECIFICALLY TARGET KIDNEYS AND METHODS OF PREPARATION AND APPLICATIONS THEREOF

METHODS AND COMPOSITIONS FOR DETERMINING RISK OF AUTISM SPECTRUM DISORDERS

TRIPLE COMBINATION ANTIBODY THERAPIES

ANTICONVULSANT AND NEUROPROTECTIVE AGENT

RECOMBINANT OPTIMIZED MECP2 CASSETTES AND METHODS FOR TREATING RETT SYNDROME AND RELATED DISORDERS

ADENO-ASSOCIATED VIRAL VECTOR FOR GLUT1 EXPRESSION AND USES THEREOF

MRNA REGULON THERAPY FOR THE TREATMENT OF HAPLOINSUFFICIENCY DISORDERS

TARGETED OESOPHAGEAL ADMINISTRATION OF ZN-ALPHA2-GLYCOPROTEINS (ZAG), METHODS AND FORMULATIONS THEREOF

THERAPEUTIC PEPTIDES

COMPOSITIONS AND METHODS FOR TREATING DISEASE

GJB2 REGULATORY ELEMENTS AND USES THEREOF

GENE EDITING SYSTEMS COMPRISING AN RNA GUIDE TARGETING STATHMIN 2 (STMN2) AND USES THEREOF

POLYPEPTIDES FOR TREATMENT OF CANCER

CYTOKINE MODULATION

METHODS AND COMPOSITIONS FOR INHIBITING FIBROSIS AND SCARRING

TREATMENT OF VAGINAL DYSBIOTIC CONDITIONS WITH ASSOCIATED ELEVATED VAGINAL CALPROTECTIN

PRODRUG COMPRISING A DRUG-LINKER CONJUGATE

USE OF LINK-TSG6 FOR THE TREATMENT OF OSTEOARTHRITIC PAIN

GENE THERAPY FOR GENETIC HEARING LOSS

POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF

WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA

COMPOUND, COMPOSITION AND METHODS FOR LOWERING CIRCULATING GLUCOSE

METHODS AND COMPOSITIONS RELATING TO CHONDRISOMES FROM BLOOD PRODUCTS

TWO-PRONGED TREATMENT FOR NIEMANN PICK TYPE C DISEASE

COMPOSITIONS AND METHODS RELATING TO PEDIATRIC NEUROMUSCULAR DISEASES AND NEUROGENERATIVE DISORDERS

BRAIN-METASTATIC LUNG CANCER CELL LINE AND USE OF NOGGIN AS MARKER FOR BRAIN METASTASIS OF LUNG CANCER

METHOD FOR MODULATING APPETITE

CIRCULAR RNA VACCINES AND METHODS OF USE THEREOF

TRIGGER NUCLEIC ACIDS AND RNA-BINDING PROTEINS FOR UPREGULATING GENE EXPRESSION

METHODS AND COMPOSITIONS FOR TREATING DIABETES, AND METHODS FOR ENRICHING MRNA CODING FOR SECRETED PROTEINS

COMPOSITIONS AND METHODS FOR TREATING CANCER

MODIFIED ADENO-ASSOCIATED VIRUS VECTOR

GENERATION OF LARGE PROTEINS BY CO-DELIVERY OF MULTIPLE VECTORS

Compositions And Methods For Regulating ZNF865

MUSCLE TARGETING COMPLEXES AND USES THEREOF FOR TREATING FRIEDREICH'S ATAXIA

COMPOSITION AND METHODS FOR MODULATION OF ELOVL2

METHODS AND COMPOSITIONS FOR REGENERATING HAIR CELLS AND/OR SUPPORTING CELLS

METHODS OF TREATING NEURODEGENERATIVE DISEASES

Reconstituted HDL Formulation

COMPOSITIONS AND METHODS FOR TREATING CANCER

DRY POWDER INHALER AND SYSTEM FOR DRUG DELIVERY

METHODS AND SYSTEMS FOR CORRECTING MUTATIONS IN PRPH2

ENGINEERED MUSCLE TARGETING COMPOSITIONS

USE OF PBX1 IN PROMOTING HAIR GROWTH

ALLEVIATING DRUG NEPHROTOXICITY

CARD9 ATTENUATES AB PATHOLOGY AND MODIFIES MICROGLIAL RESPONSES IN AN ALZHEIMER’S DISEASE

COMPOSITIONS AND METHODS FOR PREVENTION AND TREATMENT OF GENETIC DISEASE

ACTRII PROTEINS FOR THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)

COMPOSITIONS AND METHODS FOR ENHANCING CARDIOMYOCYTE TRANSPLANT ENGRAFTMENT

PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF INFLAMMATORY DISEASE OR PAIN, COMPRISING MESENCHYMAL STEM CELLS EXPRESSING PTX-3, TIMP1 AND BDNF AS ACTIVE INGREDIENT

IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING LUNG CANCER

GENE THERAPY METHODS FOR TREATMENT OF DIABETES

ENDOGENOUS GENE REGULATION TO TREAT NEUROLOGICAL DISORDERS AND DISEASES

HOST PROTEASES ESSENTIAL FOR PARAINFLUENZA SPREAD IN THE HUMAN LUNG: POTENTIAL TARGETS FOR ANTIVIRAL INTERVENTIONS

Use Of Liposomes To Deliver A Protein And A Gene Encoding The Protein To A Live Cell

Compositions and Methods for Gene Delivery to the Airways and/or Lungs

PROTEINS WITH CARDIOPROTECTIVE ACTIVITY

METHODS AND COMPOSITIONS FOR IMPROVED MOLECULAR THERAPIES OF MULTIGENIC DISEASES

COMPOSITION AND METHODS FOR TREATING RADIATION INDUCED INJURY

TREATMENT OF AGE-RELATED MACULAR DEGENERATION

COMPOSITIONS, METHODS AND USES OF MESSENGER RNA

NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING GASTROINTESTINAL AND GASTRIC CANCER

HYALURONIC ACID BINDING PEPTIDE AS A THERAPEUTIC TO CONTROL FIBROBLAST ACTIVATION AND FIBROTIC CAPSULE FORMATION

BLOCKING AND REVERSING EXTRACELLULAR VESICLE DRIVEN TRANSCRIPTOMIC TRANSFORMATION WITH ANNEXIN V TREATMENT

FUSED IN SARCOMA (FUS) NUCLEAR TRANSLOCATION INHIBITORS FOR PREVENTING FIBROSIS

METHODS AND COMPOSITIONS FOR TREATING BAG-3 RELATED CARDIOMYOPATHY WITH A VIRAL VECTOR

POLYPEPTIDE SEQUENCE OF KDM6B AND APPLICATION OF KDM6B IN REGULATING AND CONTROLLING FUNCTION OF MESENCHYMAL STEM CELL

THERAPEUTIC AGENT FOR REFRACTORY VIRAL INFECTIONS

DIAGNOSTIC AND THERAPEUTIC METHODS USING HEME AS A BIOMARKER FOR CELLULAR AND TISSUE DAMAGE

IMMUNOGLOBULINS AND USES THEREOF

HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS